American Financial Group Inc Nurix Therapeutics, Inc. Transaction History

American Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$12.94 - $29.65 $96,299 - $220,655	-7,442 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$22.71 - $36.69 $169,007 - $273,046	7,442 New	7,442 $223,000
Q2 2021 Aug 06, 2021	SELL	$24.21 - $35.89 $360,341 - $534,186	-14,884 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$26.98 - $50.17 $401,570 - $746,730	14,884 New	14,884 $462,000

184

66.3M

40.9K

106K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.15B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on American Financial Group Inc with notifications on news.